Heart study finds faulty link between biomarkers and clinical outcomes

July 14, 2017 by Colum O'connor
Heart study finds faulty link between biomarkers and clinical outcomes
Credit: stock.adobe.com

Surrogate endpoints (biomarkers), which are routinely used in clinical research to test new drugs, should not be trusted as the ultimate measure to approve new health interventions in cardiovascular medicine, according to a recent study by Yale School of Medicine researchers in JAMA.

Biomarkers generally refer to diseases, symptoms, and signs during clinical trials that are associated with other, more complicated diseases and symptoms (clinical outcomes).

In the Yale study, lead author and internal medicine resident at Yale School of Medicine Dr. Behnood Bikdeli and his colleagues examined the potential disconnect between biomarkers and clinical outcomes by screening prior publications in the field of . They found that although the surrogate endpoint trials published in the highest-impact journals frequently demonstrated high effectiveness of the tested drug, less than one third of them had a clinical outcomes trial of the drug for the same purpose published.

Additionally, when there was a subsequent trial, approximately half failed to validate the positive impact of the drug on the . Bikdeli notes that while the new findings only apply to the field of cardiovascular medicine, doctors and researchers in other fields, such as oncology, hold similar reservations about using biomarkers to approve .

Explore further: Yale researchers see decline in hospitalizations for serious heart infection

More information: Behnood Bikdeli et al. Two Decades of Cardiovascular Trials With Primary Surrogate Endpoints: 1990–2011, Journal of the American Heart Association (2017). DOI: 10.1161/JAHA.116.005285

Related Stories

Yale researchers see decline in hospitalizations for serious heart infection

September 16, 2013
Hospitalizations for endocarditis, a deadly heart infection that disproportionately affects older heart patients, have declined in recent years despite recommendations for limited use of antibiotics to prevent the illness. ...

All water pills not equally effective against heart failure

April 1, 2013
Loop diuretics, more commonly known as water pills, are the most widely prescribed heart failure medications, but few studies had extensively compared their effectiveness until Yale School of Medicine researchers examined ...

Study finds patterns of biomarkers predict how well people age, risks of age-related disease

January 6, 2017
Levels of specific biomarkers, or chemicals found in the blood, can be combined to produce patterns that signify how well a person is aging and his or risk for future aging-related diseases, according to a new study by researchers ...

Heart risks of glucose-lowering drugs being overlooked in clinical trials

March 12, 2014
Why is heart failure not more rigorously assessed in clinical trials of antidiabetes drugs? In a Personal View, published in The Lancet Diabetes & Endocrinology journal, Professor John McMurray of The University of Glasgow ...

Personalized medicine leads to better outcomes for patients with cancer

June 6, 2016
In a meta-analysis of hundreds of clinical trials involving thousands of patients, researchers at University of California San Diego School of Medicine report that therapeutic approaches using precision medicine, which emphasizes ...

Biological markers increase clinical trial success rate of new breast cancer drugs

October 1, 2012
Using biological markers—genetic characteristics that are associated with some patients with breast cancer—can increase the success rate of clinical trials for breast cancer drugs by almost 50 per cent, says new research ...

Recommended for you

Laser device placed on the heart identifies insufficient oxygenation better than other measures

September 20, 2017
A new device can assess in real time whether the body's tissues are receiving enough oxygen and, placed on the heart, can predict cardiac arrest in critically ill heart patients, report researchers at Boston Children's Hospital ...

Metabolism switch signals end for healing hearts

September 19, 2017
Researchers have identified the process that shuts down the human heart's ability to heal itself, and are now searching for a drug to reverse it.

Beta blockers not needed after heart attack if other medications taken

September 18, 2017
A new study from the University of North Carolina at Chapel Hill finds beta blockers are not needed after a heart attack if heart-attack survivors are taking ACE inhibitors and statins. The study is the first to challenge ...

Which single behavior best prevents high blood pressure?

September 15, 2017
(HealthDay)—You probably already know that certain healthy lifestyle behaviors can reduce your risk of developing high blood pressure, but is any one behavior more important than the others?

RESPECT trial shows closing a small hole in heart may protect against recurrent stroke

September 13, 2017
A device used to close a small hole in the heart may benefit certain stroke patients by providing an extra layer of protection for those facing years of ongoing stroke risk, according to the results of a large clinical trial ...

Study shows so-called 'healthy obesity' is harmful to cardiovascular health

September 11, 2017
Clinicians are being warned not to ignore the increased cardiovascular health risks of those who are classed as either 'healthy obese' or deemed to be 'normal weight' but have metabolic abnormalities such as diabetes.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.